Sec. 3001. Funding for COVID–19 vaccine activities at the centers for disease control and prevention
295 words·~1 min read·
/bill/117/hr/1319/pcs/section-3001A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
In addition to amounts otherwise available, there is appropriated to the Secretary of Health and Human Services (in this subtitle referred to as the Secretary ) for fiscal year 2021, out of any money in the Treasury not otherwise appropriated, $7,500,000,000, to remain available until expended, to carry out activities to plan, prepare for, promote, distribute, administer, monitor, and track COVID–19 vaccines. The Secretary, acting through the Director of the Centers for Disease Control and Prevention, and in consultation with other agencies, as applicable, shall, in conducting activities referred to in subsection (a)— conduct activities to enhance, expand, and improve nationwide COVID–19 vaccine distribution and administration, including activities related to distribution of ancillary medical products and supplies related to vaccines; and provide technical assistance, guidance, and support to, and award grants or cooperative agreements to, State, local, Tribal, and territorial public health departments for enhancement of COVID–19 vaccine distribution and administration capabilities, including— the distribution and administration of vaccines licensed under section 351 of the Public Health Service Act ( 42 U.S.C. 262 ) or authorized under section 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bbb–3 ) and ancillary medical products and supplies related to vaccines; the establishment and expansion, including staffing support, of community vaccination centers , particularly in underserved areas; the deployment of mobile vaccination units, particularly in underserved areas; information technology, data, and reporting enhancements, including improvements necessary to support sharing of data related to vaccine distribution and vaccinations and systems that enhance vaccine safety, effectiveness, and uptake, particularly among underserved populations; facilities enhancements; communication with the public regarding when, where, and how to receive COVID–19 vaccines; and transportation of individuals to facilitate vaccinations, including at community vaccination centers and mobile vaccination units, particularly for underserved populations.
Connectionstraces to 1
Traces to 1 document
1 reference not yet in our index
- 21 USC 360bbb–3
Citation graph
cites case law
Sec. 3001
Funding for COVID–19 vaccine activities at the centers for disease control and prevention
Cite21 USC 360bbb–3
Cites 2Cited by 0 across 0 sources